Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.

題名:	Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.
作者:	Yang, HI Yeh, ML Wong, GL Peng, CY Chen, CH Trinh, HN Cheung, KS Xie, Q Su, TH Kozuka, R Lee, DH Ogawa, E Zhao, C Ning, HB Huang, R Li, J Zhang, JQ Ide, T Xing, H Iwane, S Takahashi, H Wong, C Wong, C Lin, CH Hoang, J le, A Henry, L Toyoda, H Ueno, Y Gane, EJ Eguchi, Y Kurosaki, M Wu, C Liu, C Shang, J Furusyo, N Enomoto, M Kao, JH Yuen, MF Yu, ML Nguyen, MH
公開日期:	2020-02
關聯:	The Journal of infectious diseases 221(3), 389-399
URI:	http://ir.sinica.edu.tw/handle/201000000A/76528
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0022-1899&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://dx.doi.org/10.1093/infdis/jiz477
顯示於：	基因體研究中心

顯示文件完整紀錄

上周
0

上個月
1

checked on 2025/8/23

檢查